About

Technology

TVI-Brain-1

Pipeline

Patient Resources

News

TVAX Biomedical in the News

Stay informed with the latest updates and developments from TVAX Biomedical. This collection of select news articles and press releases reflect the company’s progress and impact in the cancer therapeutics industry.

June 29, 2023

BioSpace

Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United States patent covering the combination of an adoptive T cell therapy/oncolytic viral cancer treatment that is exclusively licensed to V2ACT Therapeutics™, LLC

View

October 18, 2022

Company Press Release

TVAX Biomedical Announces Receipt of $2 Million FDA Orphan Products Grant for Glioblastoma Study

View

April 30, 2020

Company Press Release

TVAX Biomedical Receives Fast Track Designation from the FDA

View

March 11, 2019

Company Press Release

TVAX Biomedical Names Wayne Carter as President and CEO

View

October 25, 2018

Company Press Release

ELIAS Animal Health Announces Positive Results in Treatment of Osteosarcoma in Dogs

View

November 15, 2016

Company Press Release

ELIAS Animal Health Adds Clinical Trial Site for ECI™ for the Treatment of Canine Osteosarcoma

View

August 24, 2016

Company Press Release

ELIAS Animal Health Announces First Patient Enrolled in Clinical Trial for ECI™ for the Treatment of Canine B-Cell Lymphoma

View

June 29, 2023

BioSpace

Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United States patent covering the combination of an adoptive T cell therapy/oncolytic viral cancer treatment that is exclusively licensed to V2ACT Therapeutics™, LLC

View

March 2015

Company Press Release

TVAX secures $2 million financing for animal health subsidiary

View

June 2013

KC Business

Getting Bang for the Buck in a Slow-Growth Economy

View

August 2012

Ingram’s Magazine

Exploring New Frontiers

View
Scroll to Top